Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

XTL Biopharmaceuticals (XTLB) Short Interest Ratio & Short Volume

XTL Biopharmaceuticals Short Interest Data

XTL Biopharmaceuticals (XTLB) has a short interest of 75,000 shares. This marks a -0.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 11,894 shares to cover all short positions.

Current Short Interest
75,000 shares
Previous Short Interest
75,200 shares
Change Vs. Previous Month
-0.27%
Dollar Volume Sold Short
$141,000.00
Short Interest Ratio
1.9 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
5,450,000 shares
Percentage of Shares Shorted
1.38%
Today's Trading Volume
15,652 shares
Average Trading Volume
11,894 shares
Today's Volume Vs. Average
132%
Short Selling XTL Biopharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for XTL Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

XTLB Short Interest Over Time

XTLB Days to Cover Over Time

XTLB Percentage of Float Shorted Over Time

XTL Biopharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/202475,000 shares $141,000.00 -0.3%N/A1.9 $1.88
11/15/202475,200 shares $138,368.00 -64.8%N/A1.9 $1.84
10/31/2024213,400 shares $475,882.00 +2,381.4%N/A5.4 $2.23
10/15/20248,600 shares $19,092.00 -41.5%N/A1 $2.22
9/30/202414,700 shares $35,574.00 +51.6%N/A1.4 $2.42
9/15/20249,700 shares $25,501.30 +1.0%N/A0.9 $2.63
8/31/20249,600 shares $26,784.00 -7.7%N/A0.6 $2.79
8/15/202410,400 shares $29,016.00 +103.9%N/A0.6 $2.79
7/31/20245,100 shares $14,688.00 -64.3%N/A0.3 $2.88
7/15/202414,300 shares $35,607.00 -19.2%N/A0.8 $2.49
6/30/202417,700 shares $43,011.00 +78.8%N/A0.8 $2.43
6/15/20249,900 shares $20,196.00 -55.0%N/A0 $2.04
5/31/202422,000 shares $57,200.00 -13.4%N/A0 $2.60
5/15/202425,400 shares $69,596.00 +13.4%N/A0 $2.74
4/30/202422,400 shares $57,792.00 -62.8%N/A0 $2.58
4/15/202460,200 shares $161,336.00 -86.2%N/A0.1 $2.68
3/31/2024437,200 shares $1.23 million +21,760.0%N/A0.6 $2.81
3/15/20242,000 shares $1,760.00 +11.1%N/A0 $0.88
2/29/20241,800 shares $1,531.26 -37.9%N/A0.6 $0.85
2/15/20242,900 shares $2,608.26 -42.0%N/A0.9 $0.90
1/31/20245,000 shares $4,378.50 -27.5%N/A1.4 $0.88
1/15/20246,900 shares $6,009.90 +1.5%N/A1.9 $0.87
12/31/20236,800 shares $6,868.68 -32.7%N/A1.7 $1.01
12/15/202310,100 shares $9,965.67 -15.8%N/A3.9 $0.99
11/30/202312,000 shares $12,360.00 +36.4%N/A5.7 $1.03
11/15/20238,800 shares $6,864.00 -24.8%N/A2.7 $0.78
10/31/202311,700 shares $10,148.58 +62.5%N/A3.2 $0.87
10/15/20237,200 shares $6,480.00 -22.6%N/A1.3 $0.90
9/30/20239,300 shares $8,347.68 -3.1%N/A1.7 $0.90
9/15/20239,600 shares $9,311.04 +29.7%N/A1.5 $0.97
8/31/20237,400 shares $7,770.00 +236.4%N/A0.5 $1.05
8/15/20232,200 shares $2,086.26 +29.4%N/A0.2 $0.95
7/31/20231,700 shares $1,385.84 -19.1%N/A0.1 $0.82
7/15/20232,100 shares $2,142.00 -16.0%N/A0.1 $1.02
6/30/20232,500 shares $2,376.75 -28.6%N/A0.2 $0.95
6/15/20233,500 shares $4,620.00 -25.5%N/A0.2 $1.32
5/31/20234,700 shares $5,734.00 +27.0%N/A0.6 $1.22
5/15/20233,700 shares $4,477.00 +23.3%N/A0.5 $1.21
4/30/20233,000 shares $3,360.00 -55.2%N/A0.5 $1.12
4/15/20236,700 shares $8,241.00 -23.0%N/A1.7 $1.23
Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)

To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.

Click here to learn more about the booming eHealth industry - and see which microcap will be at the
3/31/20238,700 shares $11,049.00 +117.5%N/A4.1 $1.27
3/15/20234,000 shares $4,920.00 +2.6%N/A1.6 $1.23
2/28/20233,900 shares $5,459.61 -7.1%N/A1.3 $1.40
2/15/20234,200 shares $5,586.00 -16.0%N/A1.5 $1.33
1/31/20235,000 shares $5,850.00 -12.3%N/A1.4 $1.17
1/15/20235,700 shares $7,866.00 +2,750.0%N/A1.7 $1.38
12/30/2022200 shares $242.00 -95.7%N/A0.1 $1.21
12/15/20224,700 shares $5,687.00 -6.0%N/A1 $1.21
11/30/20225,000 shares $6,650.00 +6.4%N/A1.2 $1.33
11/15/20224,700 shares $6,674.00 +261.5%N/A1 $1.42
10/31/20221,300 shares $1,677.00 -40.9%N/A0.3 $1.29
10/15/20222,200 shares $2,651.00 +83.3%N/A0.3 $1.21
9/30/20221,200 shares $1,332.00 -77.4%N/A0.2 $1.11
9/15/20225,300 shares $7,155.00 -22.1%N/A0.9 $1.35
8/31/20226,800 shares $10,064.00 +4.6%N/A1.2 $1.48
8/15/20226,500 shares $11,115.00 +8.3%N/A1.2 $1.71
7/31/20226,000 shares $9,780.00 -25.9%N/A1.1 $1.63
7/15/20228,100 shares $12,231.00 +42.1%N/A2.9 $1.51
6/30/20225,700 shares $8,664.00 +11.8%N/A1.7 $1.52
6/15/20225,100 shares $7,854.00 -13.6%N/A1.5 $1.54
5/31/20225,900 shares $10,714.99 -37.2%N/A0.9 $1.82
5/15/20229,400 shares $15,886.00 +20.5%N/A1.5 $1.69
4/30/20227,800 shares $17,160.00 +9.9%N/A1.4 $2.20
4/15/20227,100 shares $16,685.00 +16.4%N/A1.2 $2.35
3/31/20226,100 shares $14,457.00 +96.8%N/A0.9 $2.37
3/15/20223,100 shares $6,616.95 +121.4%N/A0.3 $2.13
2/28/20221,400 shares $3,332.00 -17.7%N/A0.1 $2.38
2/15/20221,700 shares $4,114.00 No ChangeN/A0.1 $2.42
1/31/20221,700 shares $4,284.00 -56.4%N/A0.1 $2.52
1/15/20223,900 shares $11,349.00 -17.0%N/A0.1 $2.91
12/31/20214,700 shares $13,019.00 +147.4%N/A0.2 $2.77
12/15/20211,900 shares $5,567.00 -64.2%N/A0.1 $2.93
11/30/20215,300 shares $16,960.00 +960.0%N/A0.2 $3.20
11/15/2021500 shares $1,790.00 -58.3%N/A0 $3.58
10/29/20211,200 shares $4,584.00 -60.0%N/A0 $3.82
10/15/20213,000 shares $11,790.00 -85.2%N/A0 $3.93
9/30/202120,200 shares $88,476.00 +1.0%N/A0.1 $4.38
9/15/202120,000 shares $82,800.00 -68.7%N/A0.1 $4.14
8/31/202163,900 shares $316,305.00 +75.6%N/A0.4 $4.95
8/13/202136,400 shares $129,220.00 -15.7%N/A0.3 $3.55
7/30/202143,200 shares $151,200.00 +37.6%N/A0.5 $3.50
7/15/202131,400 shares $108,958.00 -35.3%N/A0.4 $3.47
6/30/202148,500 shares $193,515.00 +40.2%N/A3.4 $3.99
6/15/202134,600 shares $119,370.00 -2.8%N/A2.1 $3.45
5/28/202135,600 shares $125,682.24 +14.8%N/A1.5 $3.53
5/14/202131,000 shares $103,230.00 -19.7%N/A0.1 $3.33
4/30/202138,600 shares $137,416.00 -5.6%N/A0.1 $3.56
4/15/202140,900 shares $132,516.00 -1.2%N/A0.2 $3.24
3/31/202141,400 shares $136,206.00 -19.8%N/A0.2 $3.29
3/15/202151,600 shares $174,924.00 +719.1%N/A0.2 $3.39
Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)

To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.

Click here to learn more about the booming eHealth industry - and see which microcap will be at the
2/26/20216,300 shares $19,152.00 -77.7%N/A0 $3.04
2/12/202128,200 shares $106,596.00 +464.0%N/A1 $3.78
1/29/20215,000 shares $16,100.00 -76.5%N/A0.2 $3.22
1/15/202121,300 shares $84,135.00 +88.5%N/A0.8 $3.95
12/31/202011,300 shares $35,764.50 -76.6%N/A0.4 $3.17
12/15/202048,200 shares $126,766.00 +518.0%N/A2.5 $2.63
11/30/20207,800 shares $19,573.32 -34.5%N/A0.5 $2.51
10/30/20206,900 shares $15,318.00 -46.1%N/A0.4 $2.22
10/15/202012,800 shares $27,904.00 -14.1%N/A0.7 $2.18
9/30/202014,900 shares $28,308.51 +156.9%N/A0.9 $1.90
9/15/20205,800 shares $12,586.00 +65.7%N/A0.3 $2.17
8/31/20203,500 shares $5,950.00 +483.3%N/A0.1 $1.70
8/14/2020600 shares $1,032.00 -45.5%N/A0 $1.72
7/31/20201,100 shares $1,732.50 -93.3%N/A0.1 $1.58
7/15/202016,400 shares $25,060.84 +198.2%N/A0.9 $1.53
6/30/20205,500 shares $8,525.00 -16.7%N/A0.3 $1.55
6/15/20206,600 shares $9,075.00 -7.0%N/A0.4 $1.38
5/29/20207,100 shares $9,744.75 -47.0%N/A2.1 $1.37
5/15/202013,400 shares $18,626.00 -19.3%N/A2.7 $1.39
4/30/202016,600 shares $20,160.70 -3.5%N/A2.8 $1.21
4/15/202017,200 shares $19,780.00 -1.7%N/A2.4 $1.15
3/31/202017,500 shares $20,562.50 +10.1%N/A2 $1.18
3/13/202015,900 shares $16,536.00 +1.9%N/A1.7 $1.04
2/28/202015,600 shares $15,600.00 -7.7%N/A1.4 $1.00
2/14/202016,900 shares $18,083.00 -17.6%N/A1.8 $1.07
1/31/202020,500 shares $28,700.00 -3.3%N/A2.6 $1.40
1/15/202021,200 shares $30,740.00 +40.4%N/A3.5 $1.45
12/31/201915,100 shares $19,781.00 No ChangeN/A2.7 $1.31

XTLB Short Interest - Frequently Asked Questions

What is XTL Biopharmaceuticals' current short interest?

Short interest is the volume of XTL Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 75,000 shares of XTLB short. Learn More on XTL Biopharmaceuticals' current short interest.

What is a good short interest ratio for XTL Biopharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XTLB shares currently have a short interest ratio of 2.0. Learn More on XTL Biopharmaceuticals's short interest ratio.

Is XTL Biopharmaceuticals' short interest increasing or decreasing?

XTL Biopharmaceuticals saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 75,000 shares, a decline of 0.3% from the previous total of 75,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does XTL Biopharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to XTL Biopharmaceuticals: Tempest Therapeutics, Inc. (6.72%), Affimed (4.70%), Anebulo Pharmaceuticals, Inc. (0.07%), Incannex Healthcare Inc. (0.21%), FibroGen, Inc. (3.41%), Verrica Pharmaceuticals Inc. (6.67%), RAPT Therapeutics, Inc. (3.92%), RenovoRx, Inc. (0.38%), ProMIS Neurosciences, Inc. (0.70%), Cumberland Pharmaceuticals Inc. (2.09%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short XTL Biopharmaceuticals stock?

Short selling XTLB is an investing strategy that aims to generate trading profit from XTL Biopharmaceuticals as its price is falling. XTLB shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against XTL Biopharmaceuticals?

A short squeeze for XTL Biopharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XTLB, which in turn drives the price of the stock up even further.

How often is XTL Biopharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XTLB, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:XTLB) was last updated on 12/19/2024 by MarketBeat.com Staff
From Our Partners